Clinical Trials Logo
  1. Home
  2. Venous Leg Ulcer
  3. NCT01743053

A Pilot Trial of the Use of ReCell® Autologous Cell Harvesting Device for Venous Leg Ulcers

Venous Leg Ulcers Clinical Trial

Clinical Trial Summary

This is a prospective, randomised, open label, controlled pilot study to evaluate the safety and preliminary effectiveness of the ReCell Autologous Cell Harvesting Device (ReCell) for the management of chronic leg ulcers associated with venous insufficiency. Outcome will be compared between study participants receiving standard care (debridement, compression therapy) and participants receiving ReCell in addition to standard care.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01743053
Study type Interventional
Source Avita Medical
Contact
Status Completed
Phase Phase 4
Start date January 2013
Completion date October 2015
View Details
See also
  Status Clinical Trial Phase
Completed NCT00663091 - A Prospective, Randomized, Double-Blind Controlled Study of WPP-201 for the Safety and Efficacy of Treatment of Venous Leg Ulcers Phase 1
Recruiting NCT02609594 - Amnioband and Standard of Care vs. Standard of Care Alone in the Treatment of Venous Leg Ulcers N/A
Unknown status NCT02011724 - A Study Of Pain And Quality Of Life Outcomes In Subjects With a Single Painful Venous Leg Ulcer Treated With Apligraf® Phase 4
Active, not recruiting NCT01737762 - Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm2 to ≤ 36 cm2 Phase 3
Completed NCT02222467 - Safety Evaluation of the KLOX BioPhotonic System in Venous Leg Ulcers N/A
Completed NCT01199588 - A Study to Investigate the Efficacy, Safety and Tolerability of Nexagon® as a Topical Treatment for Subjects With Venous Leg Ulcers Phase 2
Withdrawn NCT00953563 - The Mechanism of Action of Unite Biomatrix in Venous Leg Ulcers N/A
Enrolling by invitation NCT02047084 - Comparison of Human Allograft to Apligraf for Venous Leg Ulcers
Completed NCT02020746 - Efficacy and Safety Study of EscharEx to Treat (Debride) Hard to Heal Wounds Phase 2
Terminated NCT02154087 - A Phase 2 Exploratory Pharmacodynamic Study of HP802-247 in Venous Leg Ulcers Phase 2
Completed NCT02470806 - Single-Use Negative Pressure Wound Therapy System vs. Traditional Negative Pressure Wound Therapy System (tNPWT) N/A
Suspended NCT02577120 - Wound Healing Endpoint and Recurrence Phase 4
Recruiting NCT02312518 - A Prospective, Randomized Clinical Trial of PRP Concepts Fibrin Bio-Matrix in Chronic Non-Healing Venous Leg Ulcers N/A
Recruiting NCT02352454 - Effectiveness of Aurix Therapy in Venous Leg Ulcers N/A
Withdrawn NCT02940587 - Effectiveness of Aurix Therapy in Venous Leg Ulcers Phase 4
Completed NCT01036438 - Evaluating the Efficacy of an Absorbent Foam Dressing Containing Silver (Mepilex Ag) Versus the Same Dressing Without Silver Used on Subjects With Venous Leg Ulcers or Mixed Ulcers Phase 4
Unknown status NCT02224300 - Nursing Care With Patients With Venous Leg Ulcers Phase 2
Completed NCT01656889 - Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers Phase 3
Completed NCT02422017 - Topical Timolol Benefit in Venous Ulcers Phase 2